메뉴 건너뛰기




Volumn 9, Issue 2, 2006, Pages 200-203

The patient's perspective

(1)  Goodare, Heather a  

a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

EID: 33646791872     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/j.1369-7625.2006.00399.x     Document Type: Letter
Times cited : (1)

References (14)
  • 3
    • 0029118647 scopus 로고
    • Effets secondaires médicaux d'une intervention de chimioprévention: L'exemple du tamoxifène
    • Sasco AJ, Ah-Song R, Saez S, Kuttenn F. Effets secondaires médicaux d'une intervention de chimioprévention: l'exemple du tamoxifène. Bulletin du Cancer, 1995 Suppl. 82 : 186s 206s.
    • (1995) Bulletin du Cancer , vol.82
    • Sasco, A.J.1    Ah-Song, R.2    Saez, S.3    Kuttenn, F.4
  • 4
    • 0030070093 scopus 로고    scopus 로고
    • Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
    • Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. Journal of Clinical Oncology, 1996 14 : 78 84.
    • (1996) Journal of Clinical Oncology , vol.14 , pp. 78-84
    • Powles, T.J.1    Hickish, T.2    Kanis, J.A.3    Tidy, A.4    Ashley, S.5
  • 5
    • 0003875954 scopus 로고    scopus 로고
    • Carcinogenicity of tamoxifen
    • In :Kellen J.A. ed., Chapter 4. Boston : Birkhäuser Boston Inc.
    • Sasco AJ, Gendre I. Carcinogenicity of tamoxifen. In : Kellen JA ed. Tamoxifen. Beyond the Antiestrogen, Chapter 4. Boston : Birkhäuser Boston Inc., 1996 : 59 62.
    • (1996) Tamoxifen. Beyond the Antiestrogen , pp. 59-62
    • Sasco, A.J.1    Gendre, I.2
  • 7
    • 58249089215 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer
    • Early Breast Cancer Trialists' Collaborative Group., Issue. Art. No.: ED 000486. DOI: 10.1002/146651858:15.
    • Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. The Cochrane Database of Systematic Reviews, 2006, Issue 1. Art. No.: ED 000486. DOI: 10.1002/146651858:15. http://www.cochrane.org.
    • (2006) The Cochrane Database of Systematic Reviews , Issue.1
  • 8
    • 0037006449 scopus 로고    scopus 로고
    • Screening mammography: Setting the record straight (letter)
    • Goodare H, Dimmer C, Page K. Screening mammography: setting the record straight (letter). Lancet, 2002 359 : 442.
    • (2002) Lancet , vol.359 , pp. 442
    • Goodare, H.1    Dimmer, C.2    Page, K.3
  • 9
  • 10
    • 11444251764 scopus 로고    scopus 로고
    • Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    • ATAC Trialists' Group.
    • ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet, 2005 365 : 60 62.
    • (2005) Lancet , vol.365 , pp. 60-62
  • 11
    • 33645212848 scopus 로고    scopus 로고
    • Cancer information seeking
    • [See. ].
    • McPherson K. Cancer information seeking. Health Expectations, 2006 9 : 94 [See http://www.cancerbacup.org.uk ].
    • (2006) Health Expectations , vol.9 , pp. 94
    • McPherson, K.1
  • 13
    • 33646759331 scopus 로고    scopus 로고
    • Case study: I was an ATAC guinea pig
    • M. P. Case study: I was an ATAC guinea pig. What Doctors Don't Tell You, 2003 13 : 8.
    • (2003) What Doctors Don't Tell You , vol.13 , pp. 8
  • 14
    • 33645222274 scopus 로고    scopus 로고
    • Author's response to letter from Hazel Thornton and colleagues
    • Herxheimer A. Author's response to letter from Hazel Thornton and colleagues. Health Expectations, 2006 9 : 93.
    • (2006) Health Expectations , vol.9 , pp. 93
    • Herxheimer, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.